MICHAELA WHITE: Open Payments
NPI 1902671712 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,396 in 114 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $945 · 2025 $2,396
Food & beverage: $2,396
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 44 | $630 |
| Janssen Biotech, Inc. | 20 | $383 |
| Incyte Corporation | 11 | $366 |
| GENZYME CORPORATION | 4 | $191 |
| Organon LLC | 5 | $167 |
| Regeneron Healthcare Solutions, Inc. | 5 | $143 |
| Novartis Pharmaceuticals Corporation | 3 | $75 |
| Lilly USA, LLC | 3 | $66 |
| Galderma Laboratories, L.P. | 4 | $65 |
| UCB, Inc. | 3 | $65 |
Products named: RINVOQ, TREMFYA, OPZELURA, DUPIXENT, SKYRIZI, VTAMA, TALTZ, NEMLUVIO.
Industry payments across PA — which companies pay providers there.
